SEC Filings

Filing date Description Form Filing Group View
Quarterly report which provides a continuing view of a company's financial position 10-Q
Quarterly Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Additional proxy soliciting materials - definitive DEFA14A
Proxy Filings
View HTML
Official notification to shareholders of matters to be brought to a vote ("Proxy") DEF 14A
Proxy Filings
View HTML
Additional proxy soliciting materials - definitive DEFA14A
Proxy Filings
View HTML
An annual report to security holders ARS
Annual Filings
View HTML
A statement of beneficial ownership of common stock by certain persons SC 13G
Other
View HTML
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing 144
Other
View HTML
Statement of changes in beneficial ownership of securities 4
3,4,5
View HTML
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing 144
Other
View HTML
Annual report which provides a comprehensive overview of the company for the past year 10-K
Annual Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.